Platelet-Rich Protein and the Endometrium

Not Applicable

• Conditions: Infertility
• Interventions: Other: PRP injection

• Registration Number: NCT02973555
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

Platelet-rich plasma (PRP) may promote the endometrial growth and improve pregnancy outcome of patients with thin endometrium undergoing ART treatments.

Detailed Description

Not available

Study Timeline

• Status Verified: 2016-11
• Study First Submitted: 2016-11-22
• Study First Submitted QC: 2016-11-22
• Last Update Submitted: 2016-11-22
• Study First Posted: 2016-11-25
• Last Update Posted: 2016-11-25
• Study Start: 2017-01
• Primary Completion: 2018-01
• Study Completion: 2019-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

• Women undergoing a frozen thawed embryo transfer cycle with poor endometrial response to estrogen (< 7 mm) after at least two standard preparation protocols, of which one was canceled due to thin endometrium

Exclusion Criteria

• none

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
PRP injection	PRP injection	-

Primary Outcome Measures

Name	Time	Method
endometrial thickness >7mm	1 month

Secondary Outcome Measures

Name	Time	Method
Positive serum pregnancy test	14 days post embryo transfer

Trial Locations

Locations (1)

Hadassah Medical Organization; 🇮🇱 Jerusalem, Israel